The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.

On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.

米議員らは、製薬大手ファイザーが新型コロナワクチンの臨床試験（治験）結果の公表を2020年の米大統領選が終わるまで待ったかどうかを調査している。下院司法委員会の新たな書簡によると、ファイザー元社員の科学者が実験を「意図的に遅らせる」取り組みへの関与を認めたとする新たな疑惑が浮上した。

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Pfizer (PFE) stock draws public scrutiny as a House probe gathers new allegations regarding the company's COVID-19 vaccine ...

WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive ...

Covid vaccines will no longer be routinely recommended for pregnant women, teenagers and children in the US, reports suggest.

A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations ...